Booking Resort Co.,Ltd.
324A
Flier Inc.
323A
Next Generation Technology Group
319A
B-style Holdings
302A
Forcia
304A
JP Stock MarketDetailed Quotes
4588 Oncolys BioPharma
- 623
- 00.00%
20min DelayMarket to Open Feb 14 15:30 JST
15.55BMarket Cap-5.72P/E (Static)
0High0Low0Volume0Open623Pre Close0.00Turnover91852wk High0.00%Turnover Ratio24.96MShares42052wk Low-95.72EPS TTM14.17BFloat Cap4410Historical HighLossP/E (Static)22.75MShs Float401Historical Low-108.92EPS LYR0.00%Amplitude--Dividend TTM10.93P/B100Lot Size--Div YieldTTM
About Oncolys BioPharma Company
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.
Company Profile
Symbol4588
Company NameOncolys BioPharma
Founded2004-03-18
MarketTSE Growth
Fiscal Year Ends12-31
Address4-1-28 Toranomon Toranomon Towers Office
Zip Code105-0001
Phone03-5472-1578
Websitewww.oncolys.com
Company Executives
- Name
- Position
- Salary
- Yasuo Urata
- President and Chief Executive Officer, Research and Development and CMC
- --
- Yasunari Katagihara
- Director of Business Development and Risk Management
- --
- Yasushi Saitou
- Independent Director
- --
- Naoko Iino
- Independent Director
- --